The role of the complement system in CNS inflammatory diseases
- 1 May 2006
- journal article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 2 (3) , 445-456
- https://doi.org/10.1586/1744666x.2.3.445
Abstract
Complement is an important component of both the innate and adaptive immune response that contributes to host defense in a variety of mechanisms, including inflammation, phagocytosis and cell lysis. Complement proteins are produced by all cell types in the CNS, and the same effector functions that protect the host from pathogens can mediate inflammation and tissue destruction in CNS diseases, leading to neurological deficits or even death. In the last 10 years, the development of complement inhibitors and a variety of animal models for CNS diseases has revealed that targeted inhibition of complement offers significant therapeutic potential. This review discusses the subtleties of targeted complement inhibition in CNS disease as an emerging therapeutic strategy.Keywords
This publication has 94 references indexed in Scilit:
- Opportunities for New Therapies Based on the Natural Regulators of Complement ActivationAnnals of the New York Academy of Sciences, 2005
- C1q-Deficiency Is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal MiceStroke, 2005
- Brain Injury and Neuropsychological Outcome After Coronary Artery Surgery Are Affected by Complement ActivationThe Annals of Thoracic Surgery, 2005
- The alternative pathway of complement in disease: opportunities for therapeutic targetingMolecular Immunology, 2004
- Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammationThe FASEB Journal, 2003
- Vaccinia Virus Complement Control Protein Enhances Functional Recovery after Traumatic Brain InjuryJournal of Neurotrauma, 2002
- Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injuryJournal of Neuroimmunology, 1997
- The Excessive Complement Activation in Fulminant Meningococcal Septicemia Is Predominantly Caused by Alternative Pathway ActivationThe Journal of Infectious Diseases, 1996
- COMPLEMENT AND ITS COMPONENT FRACTIONS IN CEREBROSPINAL FLUID IN INFLAMMATORY CEREBROSPINAL DISEASESJournal of Clinical Investigation, 1949
- Observations on the presence of complement in the cerebrospinal fluid in various pathologic conditions of the central nervous systemThe Journal of Pediatrics, 1935